Mantle cell lymphoma (MCL) is an entity which exceptionally affects the ocular region and periorbital tissues, but which should be included in the differential diagnosis of lesions which affect the orbital region in a diffused manner. We report the case of a 60-year-old patient diagnosed with stage IV MCL, whose fi rst clinical manifestation was a result of the damage of lacrimal glands, retro-orbital tissue and ocular motor muscles. The patient was treated with rituximab and chemotherapy, achieving a complete response of those lesions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s12094-009-0389-8 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!